tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO

Crescent Biopharma (CBIO) Revenue

Compare
998 Followers

Crescent Biopharma Revenue

Crescent Biopharma had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Crescent Biopharma had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
-100.00%
P/S Ratio
Revenue/Employee
$0
Employees
33
Market Cap
$302.30M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
-10.00K
Dec 31, 2023
10.00K-65.00K+13.33%
Dec 31, 2022
75.00K-1.08M+6.47%
Dec 31, 2021
1.16M-9.00M+11.41%
Dec 31, 2020
10.16M-1,016,293,500.00%
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
-18.00K
Dec 31, 2016
18.00K